Denny Varughese, MD
Otolaryngology · Wayne, NJNPI 1821442476
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,019, 9.2 times the $111 reported in 2021.
Across 139 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$412
- Regeneron Healthcare Solutions, Inc.$340
- Optinose US, Inc.$335
- GSK$297
- Aerin Medical Inc.$266
- CSL Behring$225
- plus $677 from 17 others
What the payments were for
- Food & beverage$2,552100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 22 | $412 |
| Regeneron Healthcare Solutions, Inc. | 20 | $340 |
| Optinose US, Inc. | 21 | $335 |
| GSK | 20 | $297 |
| Aerin Medical Inc. | 8 | $266 |
| CSL Behring | 12 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $121 |
| Stryker | 4 | $108 |
| Inspire Medical Systems, Inc. | 2 | $61 |
| Kaleo, Inc. | 4 | $58 |
| Hikma Pharmaceuticals USA | 3 | $47 |
| LEO Pharma Inc. | 3 | $45 |
| Merck | 2 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Medtronic | 1 | $26 |
| Biocryst US Sales Co., LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
How this compares
$2,552 in reported general payments places this provider in the 70th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine-FluticasoneAzelastine/Fluticasone | 86 | $8,618 |
| Ipratropium Bromide | 114 | $2,462 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 21 | $2,273 |
| Fluticasone Propionate | 134 | $2,219 |
| Azelastine Hcl | 77 | $1,312 |
| Ofloxacin | 28 | $938 |
| Cefdinir | 41 | $694 |
| Methylprednisolone | 81 | $526 |
| Fluocinolone Acetonide Oil | 21 | $504 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $240 |
| Doxycycline Hyclate | 29 | $212 |
| Azithromycin | 16 | $137 |
| Mupirocin | 17 | $121 |
| Prednisone | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wayne
- Ramtin KassirWayne$8K
- Daniel ScherWayne$4K
- Vito BrunettiWayne$3K
- Matthew GliksmanWayne$3K
- Nishant ReddyEast Windsor$133K
- Giant LinFlorham Park$25K
- Samir ShahVoorhees$16K
- Brian BensonHackensack$14K
- Andrew BlitzerHackensack$9K
- Ahmad MahmoudClifton$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.